Sign in
Taking peopleNo phase

Attention Deficit Hyperactivity Disorder

Key facts

Who runs it
Nantes University Hospital
Where
France3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
11 Apr 2024
Expected to end
31 Dec 2026
Type of study
Interventional
Treatments tested
  • Patients suffering from the co-occurrence of ADHD and addiction(s)
Record updated
17 April 2026

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patients aged over 18 years
  • For whom a diagnosis of ADHD has been confirmed less than 12 weeks ago
  • For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed
  • Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)
  • For patients who can actually benefit from MPH: who have not yet started taking MPH
  • Social security affiliates

Who cannot take part

  • Patients who have used psychoactive substances within 12 hours prior to their visit
  • Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible
  • Presenting difficulties in reading or writing the French language making data collection impossible
  • Unable to commit to being available for the 2 visits planned as part of the cohort
  • Under guardianship or legal protection

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.

The group in the trial

  • Neuropsychological assessmentOther group

    Determination of the neuropsychological profile

    Treatment: Patients suffering from the co-occurrence of ADHD and addiction(s)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Addictions and Attention Deficit Disorder With or Without Hyperactivity
Fit questions
Built from NCT06232226, who can take part
Record updated
17 April 2026